Literature DB >> 23979489

Transplantation: Negative vaccination to modulate transplant immunity.

Agnes M Azimzadeh1, Jonathan S Bromberg.   

Abstract

Mesh：

Year:  2013        PMID： 23979489     DOI： 10.1038/nrneph.2013.172

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  10 in total

Review 1.  Immature, but not inactive: the tolerogenic function of immature dendritic cells.

Authors:  Karsten Mahnke; Edgar Schmitt; Laura Bonifaz; Alexander H Enk; Helmut Jonuleit
Journal:  Immunol Cell Biol       Date:  2002-10       Impact factor: 5.126

Review 2.  Manipulation of dendritic cells as an approach to improved outcomes in transplantation.

Authors:  P Toby H Coates; Bridget L Colvin; Holger Hackstein; Angus W Thomson
Journal:  Expert Rev Mol Med       Date:  2002-02-18       Impact factor: 5.600

Review 3.  Tolerogenic dendritic cells and the quest for transplant tolerance.

Authors:  Adrian E Morelli; Angus W Thomson
Journal:  Nat Rev Immunol       Date:  2007-07-13       Impact factor: 53.106

4.  Infusion of stably immature monocyte-derived dendritic cells plus CTLA4Ig modulates alloimmune reactivity in rhesus macaques.

Authors:  Alan F Zahorchak; Leslie S Kean; Daisuke Tokita; Heth R Turnquist; Masanori Abe; Jennifer Finke; Kelly Hamby; Mark R Rigby; Christian P Larsen; Angus W Thomson
Journal:  Transplantation       Date:  2007-07-27       Impact factor: 4.939

Review 5.  Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting.

Authors:  Paul J Tacken; I Jolanda M de Vries; Ruurd Torensma; Carl G Figdor
Journal:  Nat Rev Immunol       Date:  2007-10       Impact factor: 53.106

6.  Inhibitory effects of belatacept on allospecific regulatory T-cell generation in humans.

Authors:  Josh Levitsky; Joshua Miller; Xuemei Huang; Dhivya Chandrasekaran; Li Chen; James M Mathew
Journal:  Transplantation       Date:  2013-10-27       Impact factor: 4.939

7.  Belatacept and sirolimus prolong nonhuman primate renal allograft survival without a requirement for memory T cell depletion.

Authors:  D J Lo; D J Anderson; T A Weaver; F Leopardi; M Song; A B Farris; E A Strobert; J Jenkins; N A Turgeon; A K Mehta; C P Larsen; A D Kirk
Journal:  Am J Transplant       Date:  2013-01-11       Impact factor: 8.086

Review 8.  Taking dendritic cells into medicine.

Authors:  Ralph M Steinman; Jacques Banchereau
Journal:  Nature       Date:  2007-09-27       Impact factor: 49.962

9.  Regulatory dendritic cell infusion prolongs kidney allograft survival in nonhuman primates.

Authors:  M B Ezzelarab; A F Zahorchak; L Lu; A E Morelli; G Chalasani; A J Demetris; F G Lakkis; M Wijkstrom; N Murase; A Humar; R Shapiro; D K C Cooper; A W Thomson
Journal:  Am J Transplant       Date:  2013-06-11       Impact factor: 8.086

10.  Belatacept for prevention of acute rejection in adult patients who have had a kidney transplant: an update.

Authors:  David Wojciechowski; Flavio Vincenti
Journal:  Biologics       Date:  2012-11-02
  10 in total
  4 in total

1.  Eomesodermin(lo) CTLA4(hi) Alloreactive CD8+ Memory T Cells Are Associated With Prolonged Renal Transplant Survival Induced by Regulatory Dendritic Cell Infusion in CTLA4 Immunoglobulin-Treated Nonhuman Primates.

Authors:  Mohamed B Ezzelarab; Lien Lu; Hao Guo; Alan F Zahorchak; William F Shufesky; David K C Cooper; Adrian E Morelli; Angus W Thomson
Journal:  Transplantation       Date:  2016-01       Impact factor: 4.939

Review 2.  Orchestration of transplantation tolerance by regulatory dendritic cell therapy or in-situ targeting of dendritic cells.

Authors:  Adrian E Morelli; Angus W Thomson
Journal:  Curr Opin Organ Transplant       Date:  2014-08       Impact factor: 2.640

Review 3.  Regulatory dendritic cell therapy: from rodents to clinical application.

Authors:  Dalia Raïch-Regué; Megan Glancy; Angus W Thomson
Journal:  Immunol Lett       Date:  2013-12-04       Impact factor: 3.685

4.  Donor-Derived Regulatory Dendritic Cell Infusion Maintains Donor-Reactive CD4+CTLA4hi T Cells in Non-Human Primate Renal Allograft Recipients Treated with CD28 Co-Stimulation Blockade.

Authors:  Mohamed B Ezzelarab; Lien Lu; William F Shufesky; Adrian E Morelli; Angus W Thomson
Journal:  Front Immunol       Date:  2018-02-19       Impact factor: 7.561
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.